Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 June 2007

Gut. Published Online First: 21 December 2006. doi:10.1136/gut.2006.109934
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology.

Paper

Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones

Michele Pier Luca Guarino 1*, Ping Cong 2, Michele Cicala 1, Rossana Alloni 1, Simone Carotti 1 and Jose' Behar 3

1 Campus Bio Medico University, Italy
2 Rhode Island Hospital and Brown University Medical School, Providence, United States
3 Rhode Island Hospital, Providence, United States

* To whom correspondence should be addressed. E-mail: m.guarino{at}unicampus.it.

Accepted 8 December 2006


Abstract

Objective: Aim of this study was to examine the mechanisms of action of Ursodeoxycholic acid (UDCA) on on gallbladder muscle cells in symptomatic cholesterol gallstones patients since it reduces the incidence of acute cholecystitis.

Design and Patients: A double blind study was performed on 15 patients, 7 randomized to UDCA and 8 to placebo, treated for 4 weeks prior to cholecystectomy. Muscle contraction induced by CCK-8, Ach and KCl was determined in enzymatically isolated gallbladder muscle cells and cholesterol levels were determined in plasma membranes. H2O2, lipid peroxidation, PAF-like lipids, PGE2 and catalase activity were determined as biochemical markers of oxidative stress and inflammation in muscle cells.

Results: UDCA significantly increased gallbladder muscle cell contraction induced by all concentrations of CCK-8, Ach and KCl and reduced the plasma membrane cholesterol (0.32±0.16 vs 0.72±0.5 µmol/mg of protein, mean±SD) compared to placebo. UDCA treatment significantly decreased the gallbladder muscle cell levels of H2O2 (4.4±1.9 vs 13.7±5.3 µmol/mg of protein), lipid per-oxidation (MDA levels: 1.3±0.4 vs 2.52±0.7 nmol/100mg of protein), PAF-like lipids (8.9±4.9 vs 29.6±7.1 pg/mg of protein) as well as the production of PGE2 (142±47 vs 365±125 pg/mg of protein) and catalase activity (14.5±9.4 vs 35.8±12.7 units/mg of protein), when compared to placebo. In conclusion, these studies suggest that UDCA improves gallbladder muscle contractility by decreasing muscle cell cholesterol content in the plasma membranes and the biochemical parameters of oxidative stress explaining possible therapeutic mechanisms in symptomatic cholesterol gallstone patients.

Keywords: CCK, Gallbladder muscle cells, oxidative stress, plasma membranes


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Digest
Robin Spiller and Emad El-Omar
Gut 2007 56: 741. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Guarino, M P L, Carotti, S, Morini, S, Perrone, G, Behar, J, Altomare, A, Alloni, R, Caviglia, R, Emerenziani, S, Rabitti, C, Cicala, M (2008). Decreased number of activated macrophages in gallbladder muscle layer of cholesterol gallstone patients following ursodeoxycholic acid. Gut 57: 1740-1741 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs